Literature DB >> 3096988

Receptor-mediated endocytosis of interleukin 2 in a human tumor T cell line. Degradation of interleukin 2 and evidence for the absence of recycling of interleukin receptors.

V Duprez, A Dautry-Varsat.   

Abstract

We have previously described a human tumor T cell line, IARC 301, which constitutively expresses biologically functional interleukin 2 (IL2) receptors. The fate of IL2 after binding to surface high affinity receptors was investigated. After a few minutes, IL2 is internalized at 37 degrees C and is subsequently degraded and released in the medium. The half-life for surface high affinity IL2 receptors, as measured in the presence of cycloheximide, is about 1 h and does not depend upon the presence of IL2. After trypsin digestion of cell surface high affinity receptors in the absence of protein biosynthesis, we could not detect any receptor reappearance on the cell membrane, whether IL2 was added or not. Taken together these results show that IL2 receptors are constantly internalized in these cells in the presence or absence of IL2 and that they do not recycle to the plasma membrane after receptor-mediated endocytosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096988

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartments.

Authors:  A Rocca; C Lamaze; A Subtil; A Dautry-Varsat
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

2.  A conserved motif in transmembrane helix 1 of diphtheria toxin mediates catalytic domain delivery to the cytosol.

Authors:  Ryan Ratts; Carolina Trujillo; Ajit Bharti; Johanna vanderSpek; Robert Harrison; John R Murphy
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-17       Impact factor: 11.205

3.  Trans-endocytosis of intact IL-15Rα-IL-15 complex from presenting cells into NK cells favors signaling for proliferation.

Authors:  Olga M Anton; Mary E Peterson; Michael J Hollander; David W Dorward; Gunjan Arora; Javier Traba; Sumati Rajagopalan; Erik L Snapp; K Christopher Garcia; Thomas A Waldmann; Eric O Long
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

4.  Internalization of the interleukin 6 signal transducer gp130 does not require activation of the Jak/STAT pathway.

Authors:  S Thiel; I Behrmann; E Dittrich; L Muys; J Tavernier; J Wijdenes; P C Heinrich; L Graeve
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

5.  An internalized transmembrane protein resides in a fusion-competent endosome for less than 5 minutes.

Authors:  J Gruenberg; K E Howell
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

6.  Rapid cellular removal of a membrane-inserted foreign polypeptide.

Authors:  J O Moskaug; K Prydz; S Olsnes
Journal:  Biochem J       Date:  1993-04-15       Impact factor: 3.857

7.  The paramyxovirus simian virus 5 hemagglutinin-neuraminidase glycoprotein, but not the fusion glycoprotein, is internalized via coated pits and enters the endocytic pathway.

Authors:  G P Leser; K J Ector; R A Lamb
Journal:  Mol Biol Cell       Date:  1996-01       Impact factor: 4.138

8.  Combinatorial Signal Transduction Responses Mediated by Interleukin-2 and -4 Receptors in a Helper TH2 Cell Line.

Authors:  Kristen K Comfort; Jason M Haugh
Journal:  Cell Mol Bioeng       Date:  2008-09       Impact factor: 2.321

9.  Abnormal intracellular sorting of O-linked carbohydrate-deficient interleukin-2 receptors.

Authors:  K F Kozarsky; S M Call; S K Dower; M Krieger
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Defective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cells.

Authors:  J P DiSanto; F Rieux-Laucat; A Dautry-Varsat; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.